Q3 2024 VolitionRX Ltd Earnings Call Transcript

Author's Avatar
Nov 15, 2024

Nov 15, 2024 / 01:30PM GMT
Operator

To withdraw your question. Please press the star key, followed by the number two. If you're using speaker equipment, please lift the handset before making your selection. This conference is being recorded today. November 15th, 2024. I would now like to turn the conference call over to Louis Batchelor Group, Chief Marketing and Communications Officer. Please go ahead.

Louise Batchelor - VolitionRX Ltd - Chief Marketing and Communications Officer

Thank you and welcome everyone to today's conference call for volition Rx limited.

Before we begin, I'd like to remind everyone that some of the information discussed on this conference call will include forward-looking statements covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1,995.

These statements are based on our beliefs as well as assumptions we have used based upon information currently available to us because these statements reflect our current views concerning future events. These statements involve risks, uncertainties and assumptions.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot